An Update on the Current and Emerging Use of Thiazolidinediones for Type 2 Diabetes

Guidelines have increasingly stressed the concept that adequate glycemic control is required to prevent or decrease the macro- and microvascular complications of type 2 diabetes mellitus (T2DM). PPAR-gamma agonists (“glitazones”) are no longer prioritized due to their effects on heart failure. Howev...

Descripción completa

Detalles Bibliográficos
Autores principales: Giglio, Rosaria Vincenza, Papanas, Nikolaos, Rizvi, Ali Abbas, Ciaccio, Marcello, Patti, Angelo Maria, Ilias, Ioannis, Pantea Stoian, Anca, Sahebkar, Amirhossein, Janez, Andrej, Rizzo, Manfredi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9609741/
https://www.ncbi.nlm.nih.gov/pubmed/36295635
http://dx.doi.org/10.3390/medicina58101475

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9609741/
https://www.ncbi.nlm.nih.gov/pubmed/36295635
http://dx.doi.org/10.3390/medicina58101475

Ejemplares similares